Analyst PT Change

Sterne Agee analyst Sam Poser reiterated a Buy rating on Under Armour, Inc. (NYSE: UA) and raised its price target from $64 to $70.

"Comments from major retailers and accelerating dedicated shop roll-outs, double-digit year to date sales increases through May in footwear, and material international expansion opportunities will serve to continue the 20%-25% revenue growth for some time to come," the analyst states. "The June 5th investor day should provide material details as well."

The firm raised '13 &'14 EPS estimates from $1.47 and $1.89 to $1.51 and $2.00.

For an analyst ratings summary and ratings history on Under Armour, Inc. click here. For more ratings news on Under Armour, Inc. click here.

Shares of Under Armour, Inc. closed at $64.30 yesterday, with a 52 week range of $44.07-$107.86.

Wedbush today maintained an Outperform rating on American Eagle Outfitters (NYSE: AEO) with a modified price target of $25.00 (from $24.00). This morning American Eagle reported Q1 results. Analyst Betty Chen sees signs of a solid Q2.

Commenting, Chen said, "We believe the stock should react favorably to a solid Q1 beat and signs of positive early Q2. With more favorable weather, management cited a linear improvement to April, along with positive early reads on faster-selling fashion items and building momentum in knits continuing into May (with warmer
regions seeing a pop), implying flat Q2 comp guidance may prove conservative."

For an analyst ratings summary and ratings history on American Eagle Outfitters (NYSE: AEO) click here. For more ratings news on American Eagle Outfitters click here.

Shares of American Eagle Outfitters closed at $20.31 yesterday, with a 52 week range of $18.02-$23.94.

Wedbush today maintained an Outperform rating on Insmed (NASDAQ: INSM) and raised its price target to $18.00 (from $11.00). Analyst Gregory R. Wade expects a positive outcome from ARIKACE Phase III trial for CF.

"We believe that ARIKACE will meet the Phase III trial’s primary endpoint of non-inferiority to TOBI in change from baseline in FEV1 and could potentially show superiority. Positive results from the trial will support an NDA submission in the EU and US in late 2013/early 2014. We see upside to our $18 price target should ARIKACE be shown to be numerically and/or statistically superior to TOBI as we believe this data would further set the product apart in the CF market place," said Gregory R. Wade.

For an analyst ratings summary and ratings history on Insmed (NASDAQ: INSM) click here. For more ratings news on Insmed click here.

Shares of Insmed closed at $11.33 yesterday, with a 52 week range of $2.69-$12.15.

Benchmark today maintained a Buy rating on R.R. Donnelley (NASDAQ: RRD) with a modified price target of $15.00 (from $13.00) . Anayst Edward J. Atorino noted the stock's attractive dividend and potential for increased share repurchases. He also adjusted his earnings forecast to reflect new contracts.

"We are raising our 2013 revenue and EPS forecast for RR Donnelley on stronger than expected 1Q13 sales and the addition of several multi-million dollar contracts in recent weeks. We now project total revenue of $10.2 billion with EPS of $1.63, about in line with management's recent guidance, and above our previous estimates of $10.07 billion in revenues and EPS of $1.57," said Atorino.

For an analyst ratings summary and ratings history on R.R. Donnelley (NASDAQ: RRD) click here. For more ratings news on R.R. Donnelley click here.

Shares of R.R. Donnelley closed at $13.08 yesterday, with a 52 week range of $8.30-$13.30.

UBS today maintained a Buy rating on MEMC Electronic Materials (NYSE: WFR) and raised its price target to $8.00 (from $5.75). Analyst Stephen Chin thinks semi sales toughed in Q1.

"Our checks find that semi wafer starts likely troughed in 1Q13 at -2% q/q and have already seen 3 consecutive monthly increases in wafer demand with February up +15%, March +2%, and April +21% m/m, which supports our 1Q13 trough thesis. We estimate MEMC’s quarterly semi wafer sales breakeven at $225M and believe a $275M sales run rate is required to achieve its long term target operating margin of 10%, and note that MEMC produces almost 50% of its semi wafers in Japan," said Chin.

For an analyst ratings summary and ratings history on MEMC Electronic Materials (NYSE: WFR) click here. For more ratings news on MEMC Electronic Materials click here.

Shares of MEMC Electronic Materials closed at $6.72 yesterday, with a 52 week range of $1.44-$6.99.